MedTrace Logo

Fostering Self-Empowerment in CKD Patients Through Food Choice Mapping

NCT07804316 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-09-04

No results posted yet for this study

Summary

This project aims to develop mapping of food choices available for chronic kidney disease (CKD) patients when dining out in Singapore. Following the mapping, a mobile application will be developed based on renal dining out food map mobile application (RENDOFOMAP) and trialed on patients with CKD. The specific aims of the project include:

1. Mapping out food choices suitable for patients with CKD when dining out in Singapore which will eventually be translated into a mobile application incorporating simple AI functionality.
2. To evaluate the impact of using RENDOFOMAP on self-empowerment, quality of life, nutritional status, and serum biochemistry in patients with CKD.
3. To evaluate the acceptability and user experience of RENDOFOMAP

Participants with CKD will use the newly developed mobile application to find out if there is improvement in self-empowerment, quality of life, nutritional status, and serum biochemistry.

Conditions

  • CKD
  • Chronic Kidney Disease (Stages 3b-5)

Interventions

OTHER

Mobile application empowerment approach

Participant will be provided access to the prototype mobile application known for this trial. Participants will be required to utilise the mobile application for 12 days (two 6-consecutive days, twice within 3 months) during a 3-month period. During the agreed dates, participant will need to take photos of their food intake and upload them onto the mobile application for evaluation.

Sponsors & Collaborators

  • Singapore General Hospital

    collaborator OTHER

  • Sengkang General Hospital

    collaborator OTHER

  • Singapore Institute of Technology

    lead OTHER

Principal Investigators

  • Gary Tung Lin Chiah, MSc, BSc, RD · Singapore Institute of Technology

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-15
Primary Completion
2027-01-16
Completion
2027-08-16

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07804316 on ClinicalTrials.gov